Literature DB >> 15889140

Oncogenic transcription factor Evi1 regulates hematopoietic stem cell proliferation through GATA-2 expression.

Hiromi Yuasa1, Yuichi Oike, Atsushi Iwama, Ichiro Nishikata, Daisuke Sugiyama, Archibald Perkins, Michael L Mucenski, Toshio Suda, Kazuhiro Morishita.   

Abstract

The ecotropic viral integration site-1 (Evi1) is an oncogenic transcription factor in murine and human myeloid leukemia. We herein show that Evi1 is predominantly expressed in hematopoietic stem cells (HSCs) in embryos and adult bone marrows, suggesting a physiological role of Evi1 in HSCs. We therefore investigate the role and authentic target genes of Evi1 in hematopoiesis using Evi1-/- mice, which die at embryonic day 10.5. HSCs in Evi1-/- embryos are markedly decreased in numbers in vivo with defective self-renewing proliferation and repopulating capacity. Notably, expression rate of GATA-2 mRNA, which is essential for proliferation of definitive HSCs, is profoundly reduced in HSCs of Evi1-/- embryos. Restoration of the Evi1 or GATA-2 expression in Evi1-/- HSCs could prevent the failure of in vitro maintenance and proliferation of HSC through upregulation of GATA-2 expression. An analysis of the GATA-2 promoter region revealed that Evi1 directly binds to GATA-2 promoter as an enhancer. Our results reveal that GATA-2 is presumably one of critical targets for Evi1 and that transcription factors regulate the HSC pool hierarchically.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15889140      PMCID: PMC1142611          DOI: 10.1038/sj.emboj.7600679

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  35 in total

1.  The genetic program of hematopoietic stem cells.

Authors:  R L Phillips; R E Ernst; B Brunk; N Ivanova; M A Mahan; J K Deanehan; K A Moore; G C Overton; I R Lemischka
Journal:  Science       Date:  2000-06-02       Impact factor: 47.728

2.  A role for hematopoietic stem cells in promoting angiogenesis.

Authors:  N Takakura; T Watanabe; S Suenobu; Y Yamada; T Noda; Y Ito; M Satake; T Suda
Journal:  Cell       Date:  2000-07-21       Impact factor: 41.582

3.  Differential gene expression profiling of adult murine hematopoietic stem cells.

Authors:  In-Kyung Park; Yaqin He; Fangming Lin; Ole D Laerum; Qiang Tian; Roger Bumgarner; Christopher A Klug; Kaijun Li; Christian Kuhr; Michelle J Doyle; Tao Xie; Michèl Schummer; Yu Sun; Adam Goldsmith; Michael F Clarke; Irving L Weissman; Leroy Hood; Linheng Li
Journal:  Blood       Date:  2002-01-15       Impact factor: 22.113

4.  Use of chromatin immunoprecipitation to clone novel E2F target promoters.

Authors:  A S Weinmann; S M Bartley; T Zhang; M Q Zhang; P J Farnham
Journal:  Mol Cell Biol       Date:  2001-10       Impact factor: 4.272

5.  The Evi1 proto-oncogene is required at midgestation for neural, heart, and paraxial mesenchyme development.

Authors:  P R Hoyt; C Bartholomew; A J Davis; K Yutzey; L W Gamer; S S Potter; J N Ihle; M L Mucenski
Journal:  Mech Dev       Date:  1997-07       Impact factor: 1.882

6.  Characterization of definitive lymphohematopoietic stem cells in the day 9 murine yolk sac.

Authors:  M C Yoder; K Hiatt; P Dutt; P Mukherjee; D M Bodine; D Orlic
Journal:  Immunity       Date:  1997-09       Impact factor: 31.745

7.  Definitive hematopoiesis is autonomously initiated by the AGM region.

Authors:  A Medvinsky; E Dzierzak
Journal:  Cell       Date:  1996-09-20       Impact factor: 41.582

8.  'Green mice' as a source of ubiquitous green cells.

Authors:  M Okabe; M Ikawa; K Kominami; T Nakanishi; Y Nishimune
Journal:  FEBS Lett       Date:  1997-05-05       Impact factor: 4.124

9.  EVI-1 zinc finger protein works as a transcriptional activator via binding to a consensus sequence of GACAAGATAAGATAAN1-28 CTCATCTTC.

Authors:  K Morishita; K Suzukawa; T Taki; J N Ihle; J Yokota
Journal:  Oncogene       Date:  1995-05-18       Impact factor: 9.867

10.  Simplified retroviral vector gcsap with murine stem cell virus long terminal repeat allows high and continued expression of enhanced green fluorescent protein by human hematopoietic progenitors engrafted in nonobese diabetic/severe combined immunodeficient mice.

Authors:  S Kaneko; M Onodera; Y Fujiki; T Nagasawa; H Nakauchi
Journal:  Hum Gene Ther       Date:  2001-01-01       Impact factor: 5.695

View more
  78 in total

Review 1.  Evi-1 as a critical regulator of leukemic cells.

Authors:  Susumu Goyama; Mineo Kurokawa
Journal:  Int J Hematol       Date:  2010-06-08       Impact factor: 2.490

Review 2.  Molecular biology of myelodysplastic syndromes.

Authors:  Alan H Shih; Ross L Levine
Journal:  Semin Oncol       Date:  2011-10       Impact factor: 4.929

3.  Ecotopic viral integration site 1 (EVI1) regulates multiple cellular processes important for cancer and is a synergistic partner for FOS protein in invasive tumors.

Authors:  Emilie A Bard-Chapeau; Justin Jeyakani; Chung H Kok; Julius Muller; Belinda Q Chua; Jayantha Gunaratne; Arsen Batagov; Piroon Jenjaroenpun; Vladimir A Kuznetsov; Chia-Lin Wei; Richard J D'Andrea; Guillaume Bourque; Nancy A Jenkins; Neal G Copeland
Journal:  Proc Natl Acad Sci U S A       Date:  2012-01-19       Impact factor: 11.205

Review 4.  Mechanisms of self-renewal in hematopoietic stem cells.

Authors:  Zhao Wang; Hideo Ema
Journal:  Int J Hematol       Date:  2015-12-12       Impact factor: 2.490

5.  Two types of precursor cells in a multipotential hematopoietic cell line.

Authors:  Zhi-jia Ye; Yuval Kluger; Zheng Lian; Sherman M Weissman
Journal:  Proc Natl Acad Sci U S A       Date:  2005-12-13       Impact factor: 11.205

6.  Genomic and functional assays demonstrate reduced gammaretroviral vector genotoxicity associated with use of the cHS4 chromatin insulator.

Authors:  Chang Long Li; Ding Xiong; George Stamatoyannopoulos; David W Emery
Journal:  Mol Ther       Date:  2009-02-24       Impact factor: 11.454

7.  ZFP521 regulates murine hematopoietic stem cell function and facilitates MLL-AF9 leukemogenesis in mouse and human cells.

Authors:  Brian S Garrison; Adrian P Rybak; Isabel Beerman; Balthasar Heesters; Francois E Mercier; David T Scadden; David Bryder; Roland Baron; Derrick J Rossi
Journal:  Blood       Date:  2017-06-14       Impact factor: 22.113

Review 8.  Runx1/AML1 in normal and abnormal hematopoiesis.

Authors:  Tetsuya Yamagata; Kazuhiro Maki; Kinuko Mitani
Journal:  Int J Hematol       Date:  2005-07       Impact factor: 2.490

9.  MECOM-associated syndrome: a heterogeneous inherited bone marrow failure syndrome with amegakaryocytic thrombocytopenia.

Authors:  Manuela Germeshausen; Phil Ancliff; Jaime Estrada; Markus Metzler; Eva Ponstingl; Horst Rütschle; Dirk Schwabe; Richard H Scott; Sule Unal; Angela Wawer; Bernward Zeller; Matthias Ballmaier
Journal:  Blood Adv       Date:  2018-03-27

10.  Stem cell exhaustion due to Runx1 deficiency is prevented by Evi5 activation in leukemogenesis.

Authors:  Bindya Jacob; Motomi Osato; Namiko Yamashita; Chelsia Qiuxia Wang; Ichiro Taniuchi; Dan R Littman; Norio Asou; Yoshiaki Ito
Journal:  Blood       Date:  2009-12-14       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.